Total Equity - Modalis Therapeutics Corp (TSE:4883) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 69 JPY -1.43%

Updated:

Modalis Therapeutics Corp
Total Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Modalis Therapeutics Corp
Total Equity Peer Comparison

2160

4587

4974

J

7774

S

4599

Company		Total Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Modalis Therapeutics Corp TSE:4883	Total Equity ¥1.4B	CAGR 3-Years -39%	CAGR 5-Years 3%	CAGR 10-Years N/A
	GNI Group Ltd TSE:2160	Total Equity ¥34.6B	CAGR 3-Years 29%	CAGR 5-Years 30%	CAGR 10-Years 22%
	PeptiDream Inc TSE:4587	Total Equity ¥40.3B	CAGR 3-Years 24%	CAGR 5-Years 21%	CAGR 10-Years N/A
	Takara Bio Inc TSE:4974	Total Equity ¥111.5B	CAGR 3-Years 15%	CAGR 5-Years 12%	CAGR 10-Years 7%
J	Japan Tissue Engineering Co Ltd TSE:7774	Total Equity ¥6.1B	CAGR 3-Years -5%	CAGR 5-Years -5%	CAGR 10-Years 11%
S	StemRIM Inc TSE:4599	Total Equity ¥10.4B	CAGR 3-Years -1%	CAGR 5-Years 41%	CAGR 10-Years N/A

See Also

Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Total Equity amounts to 1.4B JPY.

Over the last year, the Total Equity growth was -53%. The average annual Total Equity growth rates for Modalis Therapeutics Corp have been -39% over the past three years , 3% over the past five years .

Join more than 142,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.